Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study

[1]  T. Lecompte,et al.  Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study , 2021, TH Open.

[2]  S. Susen,et al.  Anticoagulation in COVID-19: not strong for too long? , 2021, Anaesthesia Critical Care & Pain Medicine.

[3]  P. Morange,et al.  Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia , 2021, Chest.

[4]  S. Laporte,et al.  Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study , 2020, Hämostaseologie.

[5]  M. Ohana,et al.  D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients , 2020, Journal of clinical medicine.

[6]  Dong Chen,et al.  Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection , 2020, Blood.

[7]  P. Morange,et al.  Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring , 2020, Critical Care.

[8]  M. Refaai,et al.  The Clinical Significance of Fibrin Monomers , 2018, Thrombosis and Haemostasis.

[9]  Masato Sato,et al.  Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty , 2015, Journal of Orthopaedic Surgery and Research.

[10]  M. Spannagl,et al.  The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis. , 1996, Thrombosis research.